[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific Nuclear Medicine/Radiopharmaceutic Market Report 2018

March 2018 | 115 pages | ID: A9630AA10CBEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Nuclear Medicine/Radiopharmaceutic market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split Asia-Pacific into several key Regions, with sales (M Dose), revenue (Million USD), market share and growth rate of Nuclear Medicine/Radiopharmaceutic for these regions, from 2013 to 2025 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Nuclear Medicine/Radiopharmaceutic market competition by top manufacturers/players, with Nuclear Medicine/Radiopharmaceutic sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Company
  • Bracco Imaging
  • Bayer
  • Mallinckrodt
  • Nordion
  • Triad Isotopes
  • Lantheus
  • IBA Group
  • GE Healthcare
  • China Isotope & Radiation
  • Jubilant Pharma
  • Eli Lilly
  • Advanced Accelerator Applications
  • SIEMENS
  • Dongcheng
  • Navidea
On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
  • Diagnostic Radioisotopes
  • Therapeutic Radioisotopes
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Oncology
  • Cardiology
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific Nuclear Medicine/Radiopharmaceutic Market Report 2018

1 NUCLEAR MEDICINE/RADIOPHARMACEUTIC OVERVIEW

1.1 Product Overview and Scope of Nuclear Medicine/Radiopharmaceutic
1.2 Classification of Nuclear Medicine/Radiopharmaceutic by Product Category
  1.2.1 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Market Size (Sales) Comparison by Types (2013-2025)
  1.2.2 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Diagnostic Radioisotopes
  1.2.4 Therapeutic Radioisotopes
1.3 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Market by Application/End Users
  1.3.1 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales (Volume) and Market Share Comparison by Applications (2013-2025)
  1.3.2 Oncology
  1.3.3 Cardiology
  1.3.4 Others
1.4 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Market by Region
  1.4.1 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 China Status and Prospect (2013-2025)
  1.4.3 Japan Status and Prospect (2013-2025)
  1.4.4 South Korea Status and Prospect (2013-2025)
  1.4.5 Taiwan Status and Prospect (2013-2025)
  1.4.6 India Status and Prospect (2013-2025)
  1.4.7 Southeast Asia Status and Prospect (2013-2025)
  1.4.8 Australia Status and Prospect (2013-2025)
1.5 Asia-Pacific Market Size (Value and Volume) of Nuclear Medicine/Radiopharmaceutic (2013-2025)
  1.5.1 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2013-2025)
  1.5.2 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2013-2025)

2 ASIA-PACIFIC NUCLEAR MEDICINE/RADIOPHARMACEUTIC COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share of Key Players/Suppliers (2013-2018)
  2.1.2 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue and Share by Players/Suppliers (2013-2018)
2.2 Asia-Pacific Nuclear Medicine/Radiopharmaceutic (Volume and Value) by Type
  2.2.1 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Type (2013-2018)
  2.2.2 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Type (2013-2018)
2.3 Asia-Pacific Nuclear Medicine/Radiopharmaceutic (Volume) by Application
2.4 Asia-Pacific Nuclear Medicine/Radiopharmaceutic (Volume and Value) by Region
  2.4.1 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Region (2013-2018)
  2.4.2 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Region (2013-2018)

3 CHINA NUCLEAR MEDICINE/RADIOPHARMACEUTIC (VOLUME, VALUE AND SALES PRICE)

3.1 China Nuclear Medicine/Radiopharmaceutic Sales and Value (2013-2018)
  3.1.1 China Nuclear Medicine/Radiopharmaceutic Sales Volume and Growth Rate (2013-2018)
  3.1.2 China Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2013-2018)
  3.1.3 China Nuclear Medicine/Radiopharmaceutic Sales Price Trend (2013-2018)
3.2 China Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Type
3.3 China Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Application

4 JAPAN NUCLEAR MEDICINE/RADIOPHARMACEUTIC (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Nuclear Medicine/Radiopharmaceutic Sales and Value (2013-2018)
  4.1.1 Japan Nuclear Medicine/Radiopharmaceutic Sales Volume and Growth Rate (2013-2018)
  4.1.2 Japan Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2013-2018)
  4.1.3 Japan Nuclear Medicine/Radiopharmaceutic Sales Price Trend (2013-2018)
4.2 Japan Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Type
4.3 Japan Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Application

5 SOUTH KOREA NUCLEAR MEDICINE/RADIOPHARMACEUTIC (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Nuclear Medicine/Radiopharmaceutic Sales and Value (2013-2018)
  5.1.1 South Korea Nuclear Medicine/Radiopharmaceutic Sales Volume and Growth Rate (2013-2018)
  5.1.2 South Korea Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2013-2018)
  5.1.3 South Korea Nuclear Medicine/Radiopharmaceutic Sales Price Trend (2013-2018)
5.2 South Korea Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Type
5.3 South Korea Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Application

6 TAIWAN NUCLEAR MEDICINE/RADIOPHARMACEUTIC (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Nuclear Medicine/Radiopharmaceutic Sales and Value (2013-2018)
  6.1.1 Taiwan Nuclear Medicine/Radiopharmaceutic Sales Volume and Growth Rate (2013-2018)
  6.1.2 Taiwan Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2013-2018)
  6.1.3 Taiwan Nuclear Medicine/Radiopharmaceutic Sales Price Trend (2013-2018)
6.2 Taiwan Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Type
6.3 Taiwan Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Application

7 INDIA NUCLEAR MEDICINE/RADIOPHARMACEUTIC (VOLUME, VALUE AND SALES PRICE)

7.1 India Nuclear Medicine/Radiopharmaceutic Sales and Value (2013-2018)
  7.1.1 India Nuclear Medicine/Radiopharmaceutic Sales Volume and Growth Rate (2013-2018)
  7.1.2 India Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2013-2018)
  7.1.3 India Nuclear Medicine/Radiopharmaceutic Sales Price Trend (2013-2018)
7.2 India Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Type
7.3 India Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Application

8 SOUTHEAST ASIA NUCLEAR MEDICINE/RADIOPHARMACEUTIC (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales and Value (2013-2018)
  8.1.1 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume and Growth Rate (2013-2018)
  8.1.2 Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2013-2018)
  8.1.3 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Price Trend (2013-2018)
8.2 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Type
8.3 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Application

9 AUSTRALIA NUCLEAR MEDICINE/RADIOPHARMACEUTIC (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Nuclear Medicine/Radiopharmaceutic Sales and Value (2013-2018)
  9.1.1 Australia Nuclear Medicine/Radiopharmaceutic Sales Volume and Growth Rate (2013-2018)
  9.1.2 Australia Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2013-2018)
  9.1.3 Australia Nuclear Medicine/Radiopharmaceutic Sales Price Trend (2013-2018)
9.2 Australia Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Type
9.3 Australia Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Application

10 ASIA-PACIFIC NUCLEAR MEDICINE/RADIOPHARMACEUTIC PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Company
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Company Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2013-2018)
  10.1.4 Main Business/Business Overview
10.2 Bracco Imaging
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2013-2018)
  10.2.4 Main Business/Business Overview
10.3 Bayer
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Bayer Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2013-2018)
  10.3.4 Main Business/Business Overview
10.4 Mallinckrodt
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2013-2018)
  10.4.4 Main Business/Business Overview
10.5 Nordion
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Nordion Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2013-2018)
  10.5.4 Main Business/Business Overview
10.6 Triad Isotopes
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Triad Isotopes Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2013-2018)
  10.6.4 Main Business/Business Overview
10.7 Lantheus
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Lantheus Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2013-2018)
  10.7.4 Main Business/Business Overview
10.8 IBA Group
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 IBA Group Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2013-2018)
  10.8.4 Main Business/Business Overview
10.9 GE Healthcare
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2013-2018)
  10.9.4 Main Business/Business Overview
10.10 China Isotope & Radiation
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2013-2018)
  10.10.4 Main Business/Business Overview
10.11 Jubilant Pharma
10.12 Eli Lilly
10.13 Advanced Accelerator Applications
10.14 SIEMENS
10.15 Dongcheng
10.16 Navidea

11 NUCLEAR MEDICINE/RADIOPHARMACEUTIC MANUFACTURING COST ANALYSIS

11.1 Nuclear Medicine/Radiopharmaceutic Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceutic

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Nuclear Medicine/Radiopharmaceutic Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Nuclear Medicine/Radiopharmaceutic Major Manufacturers in 2017
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC NUCLEAR MEDICINE/RADIOPHARMACEUTIC MARKET FORECAST (2018-2025)

15.1 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Volume, Revenue and Price Forecast (2018-2025)
  15.1.1 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Volume and Growth Rate Forecast (2018-2025)
  15.1.2 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate Forecast (2018-2025)
  15.1.3 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Price and Trend Forecast (2018-2025)
15.2 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
  15.2.1 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Volume and Growth Rate Forecast by Region (2018-2025)
  15.2.2 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate Forecast by Region (2018-2025)
  15.2.3 China Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.4 Japan Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.5 South Korea Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.6 Taiwan Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.7 India Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.8 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.9 Australia Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Growth Rate Forecast (2018-2025)
15.3 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Price Forecast by Type (2018-2025)
  15.3.1 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Forecast by Type (2018-2025)
  15.3.2 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Type (2018-2025)
  15.3.3 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Price Forecast by Type (2018-2025)
15.4 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Forecast by Application (2018-2025)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Nuclear Medicine/Radiopharmaceutic
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) by Type (2013-2025)
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type (Product Category) in 2017
Figure Diagnostic Radioisotopes Product Picture
Figure Therapeutic Radioisotopes Product Picture
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales (M Dose) by Application (2013-2025)
Figure Asia-Pacific Sales Market Share of Nuclear Medicine/Radiopharmaceutic by Application in 2017
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Cardiology Examples
Table Key Downstream Customer in Cardiology
Figure Others Examples
Table Key Downstream Customer in Others
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Market Size (Million USD) by Region (2013-2025)
Figure China Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure South Korea Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure Taiwan Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure Australia Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) and Growth Rate (2013-2025)
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Market Major Players Product Sales Volume (M Dose)(2013-2018)
Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales (M Dose) of Key Players/Suppliers (2013-2018)
Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Share by Players/Suppliers
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Market Major Players Product Revenue (Million USD) 2013-2018
Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue Share by Players
Figure 2017 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue Share by Players
Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Type (2013-2018)
Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Share by Type (2013-2018)
Figure Sales Market Share of Nuclear Medicine/Radiopharmaceutic by Type (2013-2018)
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Growth Rate by Type (2013-2018)
Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Market Share by Type (2013-2018)
Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Nuclear Medicine/Radiopharmaceutic by Type (2013-2018)
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate by Type (2013-2018)
Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) and Market Share by Region (2013-2018)
Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Share by Region (2013-2018)
Figure Sales Market Share of Nuclear Medicine/Radiopharmaceutic by Region (2013-2018)
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region in 2017
Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Market Share by Region (2013-2018)
Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Nuclear Medicine/Radiopharmaceutic by Region (2013-2018)
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region in 2017
Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) and Market Share by Application (2013-2018)
Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Share (%) by Application (2013-2018)
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2013-2018)
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2013-2018)
Figure China Nuclear Medicine/Radiopharmaceutic Sales (M Dose) and Growth Rate (2013-2018)
Figure China Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Nuclear Medicine/Radiopharmaceutic Sales Price (USD/Dose) Trend (2013-2018)
Table China Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) by Type (2013-2018)
Table China Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type (2013-2018)
Figure China Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type in 2017
Table China Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) by Applications (2013-2018)
Table China Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application (2013-2018)
Figure China Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application in 2017
Figure Japan Nuclear Medicine/Radiopharmaceutic Sales (M Dose) and Growth Rate (2013-2018)
Figure Japan Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Nuclear Medicine/Radiopharmaceutic Sales Price (USD/Dose) Trend (2013-2018)
Table Japan Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) by Type (2013-2018)
Table Japan Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type (2013-2018)
Figure Japan Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type in 2017
Table Japan Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) by Applications (2013-2018)
Table Japan Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application (2013-2018)
Figure Japan Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application in 2017
Figure South Korea Nuclear Medicine/Radiopharmaceutic Sales (M Dose) and Growth Rate (2013-2018)
Figure South Korea Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2018)
Figure South Korea Nuclear Medicine/Radiopharmaceutic Sales Price (USD/Dose) Trend (2013-2018)
Table South Korea Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) by Type (2013-2018)
Table South Korea Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type (2013-2018)
Figure South Korea Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type in 2017
Table South Korea Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) by Applications (2013-2018)
Table South Korea Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application (2013-2018)
Figure South Korea Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application in 2017
Figure Taiwan Nuclear Medicine/Radiopharmaceutic Sales (M Dose) and Growth Rate (2013-2018)
Figure Taiwan Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2018)
Figure Taiwan Nuclear Medicine/Radiopharmaceutic Sales Price (USD/Dose) Trend (2013-2018)
Table Taiwan Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) by Type (2013-2018)
Table Taiwan Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type (2013-2018)
Figure Taiwan Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type in 2017
Table Taiwan Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) by Applications (2013-2018)
Table Taiwan Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application (2013-2018)
Figure Taiwan Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application in 2017
Figure India Nuclear Medicine/Radiopharmaceutic Sales (M Dose) and Growth Rate (2013-2018)
Figure India Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Nuclear Medicine/Radiopharmaceutic Sales Price (USD/Dose) Trend (2013-2018)
Table India Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) by Type (2013-2018)
Table India Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type (2013-2018)
Figure India Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type in 2017
Table India Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) by Application (2013-2018)
Table India Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application (2013-2018)
Figure India Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application in 2017
Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales (M Dose) and Growth Rate (2013-2018)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Price (USD/Dose) Trend (2013-2018)
Table Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) by Type (2013-2018)
Table Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type in 2017
Table Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) by Applications (2013-2018)
Table Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application in 2017
Figure Australia Nuclear Medicine/Radiopharmaceutic Sales (M Dose) and Growth Rate (2013-2018)
Figure Australia Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2018)
Figure Australia Nuclear Medicine/Radiopharmaceutic Sales Price (USD/Dose) Trend (2013-2018)
Table Australia Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) by Type (2013-2018)
Table Australia Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type (2013-2018)
Figure Australia Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type in 2017
Table Australia Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) by Applications (2013-2018)
Table Australia Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application (2013-2018)
Figure Australia Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application in 2017
Table Company Nuclear Medicine/Radiopharmaceutic Basic Information List
Table Company Nuclear Medicine/Radiopharmaceutic Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Company Nuclear Medicine/Radiopharmaceutic Sales (M Dose) and Growth Rate (2013-2018)
Figure Company Nuclear Medicine/Radiopharmaceutic Sales Market Share in Asia-Pacific (2013-2018)
Figure Company Nuclear Medicine/Radiopharmaceutic Revenue Market Share in Asia-Pacific (2013-2018)
Table Bracco Imaging Nuclear Medicine/Radiopharmaceutic Basic Information List
Table Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales (M Dose) and Growth Rate (2013-2018)
Figure Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales Market Share in Asia-Pacific (2013-2018)
Figure Bracco Imaging Nuclear Medicine/Radiopharmaceutic Revenue Market Share in Asia-Pacific (2013-2018)
Table Bayer Nuclear Medicine/Radiopharmaceutic Basic Information List
Table Bayer Nuclear Medicine/Radiopharmaceutic Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Bayer Nuclear Medicine/Radiopharmaceutic Sales (M Dose) and Growth Rate (2013-2018)
Figure Bayer Nuclear Medicine/Radiopharmaceutic Sales Market Share in Asia-Pacific (2013-2018)
Figure Bayer Nuclear Medicine/Radiopharmaceutic Revenue Market Share in Asia-Pacific (2013-2018)
Table Mallinckrodt Nuclear Medicine/Radiopharmaceutic Basic Information List
Table Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales (M Dose) and Growth Rate (2013-2018)
Figure Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales Market Share in Asia-Pacific (2013-2018)
Figure Mallinckrodt Nuclear Medicine/Radiopharmaceutic Revenue Market Share in Asia-Pacific (2013-2018)
Table Nordion Nuclear Medicine/Radiopharmaceutic Basic Information List
Table Nordion Nuclear Medicine/Radiopharmaceutic Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Nordion Nuclear Medicine/Radiopharmaceutic Sales (M Dose) and Growth Rate (2013-2018)
Figure Nordion Nuclear Medicine/Radiopharmaceutic Sales Market Share in Asia-Pacific (2013-2018)
Figure Nordion Nuclear Medicine/Radiopharmaceutic Revenue Market Share in Asia-Pacific (2013-2018)
Table Triad Isotopes Nuclear Medicine/Radiopharmaceutic Basic Information List
Table Triad Isotopes Nuclear Medicine/Radiopharmaceutic Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Triad Isotopes Nuclear Medicine/Radiopharmaceutic Sales (M Dose) and Growth Rate (2013-2018)
Figure Triad Isotopes Nuclear Medicine/Radiopharmaceutic Sales Market Share in Asia-Pacific (2013-2018)
Figure Triad Isotopes Nuclear Medicine/Radiopharmaceutic Revenue Market Share in Asia-Pacific (2013-2018)
Table Lantheus Nuclear Medicine/Radiopharmaceutic Basic Information List
Table Lantheus Nuclear Medicine/Radiopharmaceutic Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Lantheus Nuclear Medicine/Radiopharmaceutic Sales (M Dose) and Growth Rate (2013-2018)
Figure Lantheus Nuclear Medicine/Radiopharmaceutic Sales Market Share in Asia-Pacific (2013-2018)
Figure Lantheus Nuclear Medicine/Radiopharmaceutic Revenue Market Share in Asia-Pacific (2013-2018)
Table IBA Group Nuclear Medicine/Radiopharmaceutic Basic Information List
Table IBA Group Nuclear Medicine/Radiopharmaceutic Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure IBA Group Nuclear Medicine/Radiopharmaceutic Sales (M Dose) and Growth Rate (2013-2018)
Figure IBA Group Nuclear Medicine/Radiopharmaceutic Sales Market Share in Asia-Pacific (2013-2018)
Figure IBA Group Nuclear Medicine/Radiopharmaceutic Revenue Market Share in Asia-Pacific (2013-2018)
Table GE Healthcare Nuclear Medicine/Radiopharmaceutic Basic Information List
Table GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales (M Dose) and Growth Rate (2013-2018)
Figure GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales Market Share in Asia-Pacific (2013-2018)
Figure GE Healthcare Nuclear Medicine/Radiopharmaceutic Revenue Market Share in Asia-Pacific (2013-2018)
Table China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Basic Information List
Table China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales (M Dose) and Growth Rate (2013-2018)
Figure China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales Market Share in Asia-Pacific (2013-2018)
Figure China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Revenue Market Share in Asia-Pacific (2013-2018)
Table Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Basic Information List
Table Eli Lilly Nuclear Medicine/Radiopharmaceutic Basic Information List
Table Advanced Accelerator Applications Nuclear Medicine/Radiopharmaceutic Basic Information List
Table SIEMENS Nuclear Medicine/Radiopharmaceutic Basic Information List
Table Dongcheng Nuclear Medicine/Radiopharmaceutic Basic Information List
Table Navidea Nuclear Medicine/Radiopharmaceutic Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Dose) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nuclear Medicine/Radiopharmaceutic
Figure Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceutic
Figure Nuclear Medicine/Radiopharmaceutic Industrial Chain Analysis
Table Raw Materials Sources of Nuclear Medicine/Radiopharmaceutic Major Manufacturers in 2017
Table Major Buyers of Nuclear Medicine/Radiopharmaceutic
Table Distributors/Traders List
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Price (USD/Dose) and Trend Forecast (2018-2025)
Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) Forecast by Region (2018-2025)
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share Forecast by Region (2018-2025)
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share Forecast by Region in 2025
Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) Forecast by Region (2018-2025)
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue Market Share Forecast by Region (2018-2025)
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue Market Share Forecast by Region in 2025
Figure China Nuclear Medicine/Radiopharmaceutic Sales (M Dose) and Growth Rate Forecast (2018-2025)
Figure China Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Nuclear Medicine/Radiopharmaceutic Sales (M Dose) and Growth Rate Forecast (2018-2025)
Figure Japan Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure South Korea Nuclear Medicine/Radiopharmaceutic Sales (M Dose) and Growth Rate Forecast (2018-2025)
Figure South Korea Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Taiwan Nuclear Medicine/Radiopharmaceutic Sales (M Dose) and Growth Rate Forecast (2018-2025)
Figure Taiwan Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Nuclear Medicine/Radiopharmaceutic Sales (M Dose) and Growth Rate Forecast (2018-2025)
Figure India Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales (M Dose) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Australia Nuclear Medicine/Radiopharmaceutic Sales (M Dose) and Growth Rate Forecast (2018-2025)
Figure Australia Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales (M Dose) Forecast by Type (2018-2025)
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by Type (2018-2025)
Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) Forecast by Type (2018-2025)
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue Market Share Forecast by Type (2018-2025)
Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Price (USD/Dose) Forecast by Type (2018-2025)
Table Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales (M Dose) Forecast by Application (2018-2025)
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories